Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia

Leuk Lymphoma. 2011 Jan;52(1):134-6. doi: 10.3109/10428194.2010.512965. Epub 2010 Sep 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Agents / adverse effects*
  • Azacitidine / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Pancytopenia / chemically induced
  • Pancytopenia / prevention & control*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Prognosis

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Azacitidine